NCT02560571Unknown2 期
Preoperative Evaluation of Endometrial Cancer
适应症
试验速览
- 阶段
- 2 期
- 入组人数
- 200
- 试验地点
- 1
- 主要终点
- number of participants with positive nodes
研究概览
简要总结
The study evaluates pre-operative prediction of the risk for lymph nodes involvement in endometrial cancer patients. Patients will undergo ultrasound exam (bi and three dimensional) and biomarker test - Ca 125, in addition to routine physical and laboratory exams, before surgery.
The sonographic evaluation will include endometrial characteristics and myometrial invasion, pelvic findings and enlarged lymph nodes.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Diagnostic
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- Female
- 接受健康志愿者
- 否
入选标准
- •Endometrial cancer patients
- •Surgical candidates
排除标准
- •Fertility preservation therapy
- •Contraindication for surgery
- •Stage 2 and higher
结局指标
主要结局
number of participants with positive nodes
时间窗: 4 weeks after surgery (4-6 weeks from enrollment)
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
进行中（未招募）
不适用
Targeting Inflammation for Endometrial Cancer PreventionEndometrial CarcinomaNCT05407025Mayo Clinic191
招募中
不适用
Early Detection of Endometrial Cancer Using Plasma Cell-free DNA FragmentomicsEndometrial CancerNCT06083779Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University216
撤回
1 期
Efficacy and Safety Study of Lurbinectedin and Dostarlimab in Cancer Patients: Protocol VHIO21001 - LiDerEndometrial CancerNCT06385548Vall d'Hebron Institute of Oncology15
进行中（未招募）
不适用
Prediction of Recurrence Among Low Risk Endometrial Cancer PatientsFIGO Grade 1 Endometrial Endometrioid AdenocarcinomaFIGO Grade 2 Endometrial Endometrioid AdenocarcinomaNCT04604613M.D. Anderson Cancer Center518
Unknown
不适用
Endometrial Cancer International DatabaseEndometrial CancerNCT04787159Assiut University1,000